Pfizer Inc.
FDA Authorizes Pfizer-BioNTech Vaccine for Adolescents Aged 12-15 Years
The Food and Drug Administration has granted emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years, marking a significant milestone in the country's vaccination efforts. This expansion of vaccine eligibility offers protection against COVID-19 for millions of children during summer activities and raises hopes